nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Hypothermia—Metformin—polycystic ovary syndrome	0.028	0.0776	CcSEcCtD
Remifentanil—Body temperature decreased—Metformin—polycystic ovary syndrome	0.028	0.0776	CcSEcCtD
Remifentanil—Respiratory distress—Metformin—polycystic ovary syndrome	0.0247	0.0684	CcSEcCtD
Remifentanil—Heartburn—Metformin—polycystic ovary syndrome	0.0228	0.0632	CcSEcCtD
Remifentanil—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0194	0.0537	CcSEcCtD
Remifentanil—Nasal congestion—Metformin—polycystic ovary syndrome	0.0125	0.0346	CcSEcCtD
Remifentanil—Renal impairment—Metformin—polycystic ovary syndrome	0.012	0.0332	CcSEcCtD
Remifentanil—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0102	0.0282	CcSEcCtD
Remifentanil—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00944	0.0261	CcSEcCtD
Remifentanil—Bradycardia—Metformin—polycystic ovary syndrome	0.00802	0.0222	CcSEcCtD
Remifentanil—Flushing—Metformin—polycystic ovary syndrome	0.00731	0.0203	CcSEcCtD
Remifentanil—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00731	0.0203	CcSEcCtD
Remifentanil—Angiopathy—Metformin—polycystic ovary syndrome	0.00715	0.0198	CcSEcCtD
Remifentanil—Immune system disorder—Metformin—polycystic ovary syndrome	0.00712	0.0197	CcSEcCtD
Remifentanil—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0071	0.0197	CcSEcCtD
Remifentanil—Chills—Metformin—polycystic ovary syndrome	0.00707	0.0196	CcSEcCtD
Remifentanil—Erythema—Metformin—polycystic ovary syndrome	0.00686	0.019	CcSEcCtD
Remifentanil—Tremor—Metformin—polycystic ovary syndrome	0.00642	0.0178	CcSEcCtD
Remifentanil—Syncope—Metformin—polycystic ovary syndrome	0.00615	0.017	CcSEcCtD
Remifentanil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00603	0.0167	CcSEcCtD
Remifentanil—Hypertension—Metformin—polycystic ovary syndrome	0.00592	0.0164	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0058	0.0161	CcSEcCtD
Remifentanil—Oedema—Metformin—polycystic ovary syndrome	0.0056	0.0155	CcSEcCtD
Remifentanil—Shock—Metformin—polycystic ovary syndrome	0.00551	0.0153	CcSEcCtD
Remifentanil—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00549	0.0152	CcSEcCtD
Remifentanil—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00548	0.0152	CcSEcCtD
Remifentanil—Skin disorder—Metformin—polycystic ovary syndrome	0.00544	0.0151	CcSEcCtD
Remifentanil—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00541	0.015	CcSEcCtD
Remifentanil—Hypotension—Metformin—polycystic ovary syndrome	0.00523	0.0145	CcSEcCtD
Remifentanil—Paraesthesia—Metformin—polycystic ovary syndrome	0.00503	0.0139	CcSEcCtD
Remifentanil—Dyspnoea—Metformin—polycystic ovary syndrome	0.00499	0.0138	CcSEcCtD
Remifentanil—Somnolence—Metformin—polycystic ovary syndrome	0.00498	0.0138	CcSEcCtD
Remifentanil—Dyspepsia—Metformin—polycystic ovary syndrome	0.00493	0.0137	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00483	0.0134	CcSEcCtD
Remifentanil—Constipation—Metformin—polycystic ovary syndrome	0.00479	0.0133	CcSEcCtD
Remifentanil—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00461	0.0128	CcSEcCtD
Remifentanil—Urticaria—Metformin—polycystic ovary syndrome	0.00445	0.0123	CcSEcCtD
Remifentanil—Pruritus—Metformin—polycystic ovary syndrome	0.00396	0.011	CcSEcCtD
Remifentanil—Diarrhoea—Metformin—polycystic ovary syndrome	0.00383	0.0106	CcSEcCtD
Remifentanil—Dizziness—Metformin—polycystic ovary syndrome	0.0037	0.0103	CcSEcCtD
Remifentanil—Vomiting—Metformin—polycystic ovary syndrome	0.00356	0.00986	CcSEcCtD
Remifentanil—Rash—Metformin—polycystic ovary syndrome	0.00353	0.00978	CcSEcCtD
Remifentanil—Dermatitis—Metformin—polycystic ovary syndrome	0.00353	0.00977	CcSEcCtD
Remifentanil—Headache—Metformin—polycystic ovary syndrome	0.00351	0.00972	CcSEcCtD
Remifentanil—Nausea—Metformin—polycystic ovary syndrome	0.00332	0.00921	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00117	0.00183	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00116	0.00181	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00113	0.00176	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00113	0.00176	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00113	0.00176	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00112	0.00175	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00111	0.00174	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.0011	0.00173	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00109	0.00171	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00109	0.00171	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00108	0.00169	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00108	0.00169	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00107	0.00168	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00107	0.00168	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00107	0.00167	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00106	0.00167	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00106	0.00166	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00105	0.00165	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00104	0.00163	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00103	0.00161	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00102	0.0016	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00102	0.00159	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.001	0.00157	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000998	0.00156	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000996	0.00156	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000994	0.00156	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000982	0.00154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000978	0.00153	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000975	0.00152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000972	0.00152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000967	0.00151	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000955	0.00149	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000952	0.00149	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000945	0.00148	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000945	0.00148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000942	0.00147	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000934	0.00146	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.000933	0.00146	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000931	0.00146	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000922	0.00144	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000913	0.00143	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000911	0.00143	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000907	0.00142	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000906	0.00142	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000904	0.00141	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000903	0.00141	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000897	0.0014	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000897	0.0014	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000891	0.00139	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000875	0.00137	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000864	0.00135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000858	0.00134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000852	0.00133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000848	0.00133	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000844	0.00132	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000839	0.00131	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000837	0.00131	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000835	0.00131	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00083	0.0013	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000829	0.0013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000824	0.00129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000815	0.00127	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000799	0.00125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000796	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000794	0.00124	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000792	0.00124	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000789	0.00123	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000787	0.00123	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000787	0.00123	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000787	0.00123	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000772	0.00121	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000771	0.00121	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000763	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000758	0.00119	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000753	0.00118	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00074	0.00116	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000739	0.00116	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL6—polycystic ovary syndrome	0.000737	0.00115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000736	0.00115	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000725	0.00113	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000721	0.00113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00072	0.00113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000717	0.00112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000714	0.00112	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000708	0.00111	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000705	0.0011	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000703	0.0011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.0007	0.0011	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000695	0.00109	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000677	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000671	0.00105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000665	0.00104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000665	0.00104	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000657	0.00103	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000643	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000641	0.001	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000638	0.000999	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000632	0.000989	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000626	0.000979	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000622	0.000973	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000617	0.000966	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000616	0.000964	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000604	0.000944	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.0006	0.000939	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000587	0.000919	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FST—polycystic ovary syndrome	0.000585	0.000916	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000582	0.00091	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000578	0.000904	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000576	0.000901	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000572	0.000895	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000571	0.000894	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000564	0.000882	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00056	0.000876	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000558	0.000873	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000541	0.000847	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000541	0.000846	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00054	0.000844	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000535	0.000837	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000534	0.000836	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000528	0.000827	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000527	0.000824	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000521	0.000815	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FST—polycystic ovary syndrome	0.000513	0.000803	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000511	0.000799	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00051	0.000798	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000507	0.000793	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000502	0.000785	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000501	0.000784	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000498	0.000778	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00049	0.000767	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00049	0.000766	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000487	0.000761	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000476	0.000745	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000474	0.000742	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000473	0.00074	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000473	0.00074	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000469	0.000734	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000465	0.000727	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000463	0.000725	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000458	0.000717	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000457	0.000716	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000448	0.0007	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000445	0.000696	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00044	0.000688	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000438	0.000685	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000436	0.000683	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000434	0.000678	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000431	0.000675	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00043	0.000672	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000428	0.00067	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000423	0.000662	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000416	0.000651	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000414	0.000647	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00041	0.000641	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000407	0.000637	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000406	0.000635	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000402	0.000629	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000401	0.000627	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0004	0.000626	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000397	0.000621	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000392	0.000613	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000384	0.000601	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000378	0.000592	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000377	0.00059	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000377	0.00059	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000372	0.000582	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000369	0.000577	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000365	0.000571	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000363	0.000568	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000363	0.000568	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00036	0.000563	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000359	0.000562	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000356	0.000556	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000351	0.000549	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000349	0.000546	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000344	0.000539	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00034	0.000531	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000332	0.000519	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000331	0.000517	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000331	0.000517	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00033	0.000516	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000329	0.000515	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000325	0.000508	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000319	0.000498	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000317	0.000496	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000315	0.000494	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000312	0.000488	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000308	0.000483	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000308	0.000481	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000306	0.000479	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000304	0.000475	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000301	0.00047	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000291	0.000455	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000289	0.000453	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000289	0.000453	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000289	0.000451	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000279	0.000437	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000279	0.000437	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000278	0.000435	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000276	0.000431	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000274	0.000428	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000271	0.000423	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000269	0.000421	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000267	0.000417	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00026	0.000407	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000259	0.000405	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000254	0.000397	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000246	0.000385	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000244	0.000382	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000244	0.000381	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000242	0.000378	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000237	0.000371	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000235	0.000368	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000232	0.000363	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000231	0.000362	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000227	0.000355	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000214	0.000336	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000204	0.00032	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000203	0.000318	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000202	0.000317	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000201	0.000314	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000199	0.000311	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000195	0.000305	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000194	0.000303	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000187	0.000293	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000187	0.000293	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000178	0.000279	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000177	0.000278	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000172	0.000269	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000171	0.000267	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	0.00017	0.000266	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000168	0.000263	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000164	0.000257	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000164	0.000257	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000156	0.000244	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00015	0.000235	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000144	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000144	0.000225	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000143	0.000224	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000139	0.000217	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000139	0.000217	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000132	0.000206	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000126	0.000197	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000122	0.000192	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000107	0.000168	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000106	0.000166	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.07e-05	0.000142	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	8.47e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	7.43e-05	0.000116	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	6.28e-05	9.82e-05	CbGpPWpGaD
